Photograph of Yuezhong Feng, Ph.D.

Yuezhong Feng, Ph.D.

Partner


With a Ph.D. in organic chemistry, Yuezhong Feng is used to handling challenging subject matter. He puts his technical knowledge to work litigating complex patent, Hatch-Waxman (ANDA), trade secret, International Trade Commission Section 337, and USPTO post-grant (inter partes review) cases, as well as guiding clients through the patent process. He also counsels clients on all aspects of U.S. intellectual property laws.

As co-chair of the firm’s China task force, Yuezhong often works with Chinese businesses entering the U.S. market. He excels at helping these clients bridge the gap between Chinese business and legal cultures and those found in the United States. As a result, companies in diverse industries rely on him to help maximize profit and reduce risk at every step of the patent process, from identifying patentable inventions to developing prosecution strategies, to portfolio management and monetization, to enforcement. Due to his deep understanding of Chinese markets, Yuezhong frequently assists U.S. and European companies with intellectual property issues in China.

Yuezhong has helped companies seek patent protection in more than 100 countries. In preparing patent applications, he thinks forward toward how to achieve consistent protection in global markets worldwide.

Yuezhong has particular experience in the chemical, pharmaceuticals, biotechnology, biopharma, nanotechnology, electrical vehicles, chemical engineering (particularly bio-fuels and bio-diesels), mechanical (particularly home appliances and e-cigarettes), and electrical engineering (particularly telecommunication and liquid-crystal display devices) arts.

Prior to joining Crowell & Moring, he was a shareholder at Brinks Gilson & Lione.

Education

  • Beijing University, B.S. chemistry, minor in law (1995)
  • University of Chicago, Ph.D. organic chemistry (2002)
  • University of Illinois Chicago School of Law, J.D. (2009)

Affiliations

  • Licensing Executives Society
  • ITC Trial Lawyers Association
  • American Chemical Society

Admissions

Admitted to practice: Illinois, U.S. Patent and Trademark Office (USPTO)

View More

Practices

Intellectual Property

Intellectual Property Litigation

IP Strategy, Prosecution and Portfolio Management

Health Care

Life Sciences

Trade Secrets

Patent Litigation

Pharmaceutical and Biologics Litigation

Design Protection

U.S. ITC Section 337

Post-Grant Proceedings

Patent Prosecution

IP Transactions and Diligence

U.S. ITC Section 337

Renewable Energy

Medical Devices

Digital Health/MedTech

Show more practices…

  • Certain Video Processing Devices, Components Thereof, and Digital Smart Televisions Containing the Same, ITC Inv. No. 337-TA-1222. Representing TCL respondents in the ITC action and corresponding district court case.
  • DivX, LLC v. MediaTek Inc., et al., No. 1:20-cv-01203 (D. Del. filed September 9, 2020). Representing TCL in the district court patent action.
  • Polaris PowerLED Technologies, LLC v. TCL Corporation et al, No. 8:20-cv-00127 (C.D. Cal. filed January 21, 2020). Represented TCL in the district court patent action and corresponding IPR proceeding. The case settled in terms favorable to TCL.
  • American Patents LLC v. Hisense Co. Ltd. et al., No. 4:18-cv-00768 (E.D. Tex. filed October 26, 2018). Represented Hisense in the district court patent action.
  • American Patents LLC v. ZTE Corporation et al, No. 4:18-cv-00675 (E.D. Tex. filed September 24, 2018). Represented ZTE in the district court patent action.
  • Pfizer v. Sandoz Inc. (D.N.J.). Litigated patents under Hatch Waxman (ANDA) related to pregabalin sold by Pfizer as Lyrica©, working on all aspects of the case including discovery, expert testimony, briefing, witness preparation and depositions.
  • Avanir Pharmaceuticals, Inc. et al. v. Watson Pharmaceuticals, Inc. (D. Del.). Represented Watson in patent litigation under Hatch Waxman (ANDA) related to dextromethorphan hydrobromide quinidine sulfate sold by Avanir as Nuedexta©.
  • Teijin Ltd., Teijin Pharma Ltd., and Takeda Pharma. U.S.A., Inc. v. Alembic Pharma. Ltd. (D. Del.). Representing Alembic in patent litigation under Hatch Waxman (ANDA) related to febuxostat sold by Takeda as Uloric®.
  • R.J. Reynolds Vapor Company v. Fontem Holdings 1 B.V., Nos. 2018-1591, -1598 (Fed. Cir. 2018). Represented R.J. Reynolds Vapor Co. in appealing decisions of the Patent Trial and Appeal Board.
  • Fontem Ventures B.V. and Fontem Holdings 1 B.V. v. R.J. Reynolds Vapor Co. (C.D. Cal. 2016-present; transferred to M.D.N.C.). Represented R.J. Reynolds Vapor Co. in the district court patent actions.
  • AstraZeneca LP et al. v. Hisun Pharmaceutical (Hangzhou) Co., Ltd. et al., C. A. No. 1:18-cv-1232 (D. Del filed August 10, 2018). Represented Hisun in patent litigation under Hatch Waxman (ANDA) related to ticagrelor sold by AstraZeneca as Brilinta®.
  • Codec Technologies LLC v. Coolpad Technologies Inc., C.A. No. 2:16-cv-00307 (E.D. Tex filed March 30, 2016). Represented Coolpad Technologies Inc. in the district court patent action.
  • AstraZeneca LP et al. v. Hisun Pharmaceutical (Hangzhou) Co., Ltd. et al., C. A. No. 1:15-cv-1042 (D. Del. filed November 12, 2015). Represented Hisun in patent litigation under Hatch Waxman (ANDA) related to ticagrelor sold by AstraZeneca as Brilinta®.
  • Noven Therapeutics, LLC. v. Actavis Laboratories FL, Inc., et al., C. A. Nos. 2:14-cv-6414 (D.N.J. filed October 16, 2014) and 2:15-cv-06225 (D.N.J. filed August 14, 2015)(consolidated). Represented Actavis in patent litigation under Hatch Waxman (ANDA) related to paroxetine mesylate sold by Noven as Brisdelle®.
  • InterDigital Communications, Inc. et al. v. ZTE Corp., and ZTE (USA) Inc., (D. Del.); Technology Properties Limited, LLC et al. v. ZTE Corp., and ZTE (USA) Inc. (N. D. Cal.); InterDigital Comm., LLC, InterDigital Tech. Corp., And IPR Licensing, Inc. v. Huawei Tech. Co., Ltd., Futurewei Tech., Inc. d/b/a Huawei Tech. (USA) America, Nokia Corp., Nokia Inc., ZTE Corp., And ZTE (USA) Inc., (D. Del.); Certain Wireless Consumer Electronics Devices and Components Thereof (ITC); Certain Wireless Devices With 3G And/Or 4G Capabilities And Components Thereof (ITC.) Successfully represented ZTE Corporation and ZTE (USA) Inc. in actions at the International Trade Commission and U.S. federal district court, preserving ZTE’s ability to do business in the United States.
  • Certain Wireless Devices With 3G and/or 4G Capabilities And Components Thereof, ITC Inv. No. 337-TA-868. Represented respondents ZTE Corporation and ZTE (USA) Inc. in the ITC investigation.
  • InterDigital Communications, Inc. et al. v. ZTE Corp., and ZTE (USA) Inc., C. A. No. 13-00009-RGA (D. Del. filed January 2, 2013). Represented defendants ZTE Corporation and ZTE (USA) Inc. in the district court patent action.
  • Certain Wireless Consumer Electronics Devices and Components Thereof, ITC Inv. No. 337-TA-853. Represented respondents ZTE Corporation and ZTE (USA) Inc. in the ITC investigation.
  • Technology Properties Limited, LLC et al. v. ZTE Corp., and ZTE (USA) Inc., C. A. No. 12-03876-PSG (N. D. Cal. filed July 24, 2012). Represented defendants ZTE Corporation and ZTE (USA) Inc. in the district court patent action. Certain Wireless Consumer Electronics Devices and Components Thereof, ITC Inv. No. 337-TA-853. Represented respondents ZTE Corporation and ZTE (USA) Inc. in the ITC investigation.
  • Certain Wireless Devices With 3G Capabilities and Components Thereof, ITC No. 337-TA-800. Represented respondents ZTE Corporation and ZTE (USA) Inc. in the ITC investigation.
  • InterDigital Comm., LLC, InterDigital Tech. Corp., And IPR Licensing, Inc. v. Huawei Tech. Co., Ltd., Futurewei Tech., Inc. d/b/a Huawei Tech. (USA) America, Nokia Corp., Nokia Inc., ZTE Corp., And ZTE (USA) Inc., C. A. No. 11-654-MSG (D. Del. filed July 28, 2011). Represented defendants ZTE Corporation and ZTE (USA) Inc. in the district court patent action.
  • Long Corner Consumer Electronics LLC v. Coolpad Technologies Inc., C. A. No. 2:13-cv-1004 (E. D. Tex. filed November 26, 2013). Represented Coolpad Technologies Inc. in the district court patent action.
  • Certain Electric Fireplaces, Components Thereof, Manuals For Same, Certain Processes For Manufacturing Or Relating To Same, And Certain Products Containing Same, ITC No. 337-TA-791. Represented complainants Twin-Star International, Inc. and TS Investment Holding Corp. in the ITC investigation.
"Federal Circuit Opinion on Heart Medication May Raise Generics' Blood Pressure," IP Insights (October 8, 2020). Contacts: Yuezhong Feng, Ph.D., Joshua P. Smith
Client Alert / Newsletter
"Subject Matter Eligibility for Graphical User Interfaces," IP Insights (February 14, 2018). Contact: Yuezhong Feng, Ph.D.
Client Alert / Newsletter
Brinks New Shareholders mentioned in CDLB Chicago Daily Law Bulletin (January 20, 2016)
Press Coverage
The Effect of Daimler AG v. Bauman on Personal Jurisdiction in Hatch-Waxman Lawsuits (January 20, 2015). Author: Yuezhong Feng
Publication
"Non-Party Discovery Involving a U.S. Entity and Its Foreign Affiliate: A Comparison of the Commission's Approach to Subpoenas and the Hague Evidence Convention," Section 337 Reporter - Sixth Annual Summer Associate Edition (Summer 2008). Author: Yuezhong Feng
Publication
"Direct Cell Adhesion to the Angiopoietins Mediated by Integrins." Co-author, 276, 26516-26525.," J. Biol. Chem. Author: Yuezhong Feng
Publication
""The Synergy Peptide PHSRN and the Adhesion Peptide RGD Mediate Cell Adhesion through a Common Mechanism," Co-author, 43, 15811-15821.," Biochemistry Author: Yuezhong Feng
Publication

For all Highlights, News & Knowledge, please click here to view desktop bio.

Crowell & Moring LLP is an international law firm with offices in the United States, Europe, MENA, and Asia that represents clients in litigation and arbitration, regulatory and policy, and transactional and corporate matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation and government-facing matters, as well as its ongoing commitment to pro bono service and diversity, equity, and inclusion.

View Desktop Site | Mobile Sitemap |

Contact | Subscribe | Terms of Use | Privacy Statement | Alumni

© Crowell & Moring LLP 2022
Attorney advertising - prior results do not guarantee a similar outcome.